Company page

Drugs Made In America Acquisition Corp.

Drugs Made In America Acquisition Corp. (DMAA) is a public company focused on the pharmaceutical sector in the United States. With a market capitalization of approximately $258 million, the company aims to contribute to the domestic production of drugs. DMAA is positioned to capitalize on the growing demand for American-made pharmaceuticals.